Napatech A/S (LON:0QJ4)
33.35
0.00 (0.00%)
At close: Dec 5, 2025
Napatech Revenue
Napatech had revenue of 40.13M DKK in the quarter ending September 30, 2025, with 18.00% growth. This brings the company's revenue in the last twelve months to 133.23M, down -2.62% year-over-year. In the year 2024, Napatech had annual revenue of 116.41M, down -36.28%.
Revenue (ttm)
133.23M DKK
Revenue Growth
-2.62%
P/S Ratio
16.82
Revenue / Employee
1.42M DKK
Employees
94
Market Cap
261.87M GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 116.41M | -66.27M | -36.28% |
| Dec 31, 2023 | 182.67M | 24.05M | 15.16% |
| Dec 31, 2022 | 158.63M | -36.84M | -18.85% |
| Dec 31, 2021 | 195.47M | 1.24M | 0.64% |
| Dec 31, 2020 | 194.23M | 23.63M | 13.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |